High expression of PARD3 predicts poor prognosis in hepatocellular carcinoma

Código QR

High expression of PARD3 predicts poor prognosis in hepatocellular carcinoma

Abstract Hepatocellular carcinoma (HCC) is one of the most commonly cancers with poor prognosis and drug response. Identifying accurate therapeutic targets would facilitate precision treatment and prolong survival for HCC. In this study, we analyzed liver hepatocellular carcinoma (LIHC) RNA sequenci...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Songwei Li, Jian Huang, Fan Yang, Haiping Zeng, Yuyun Tong, Kejia Li
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/d46a0ce8208a4ba9aedc4eebbc834fa2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

High expression of transmembrane P24 trafficking protein 9 predicts poor prognosis in breast carcinoma
por: Gaoda Ju, et al.
Publicado: (2021)

High expression of GOLPH3 in esophageal squamous cell carcinoma correlates with poor prognosis.
por: Jian-Hua Wang, et al.
Publicado: (2012)

Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a.
por: Chan Xie, et al.
Publicado: (2012)

Increased ATG5 Expression Predicts Poor Prognosis and Promotes EMT in Cervical Carcinoma
por: Suna Zhou, et al.
Publicado: (2021)

Increased Serum Pentraxin 3 Levels are Associated with Poor Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma
por: Han Q, et al.
Publicado: (2021)

High expression of IMPDH2 is associated with aggressive features and poor prognosis of primary nasopharyngeal carcinoma
por: Yi Xu, et al.
Publicado: (2017)

HHLA2 Expression is Associated with Poor Survival in Patients with Hepatocellular Carcinoma
por: Xu Y, et al.
Publicado: (2021)

The novel immune-related genes predict the prognosis of patients with hepatocellular carcinoma
por: Lunxu Li, et al.
Publicado: (2021)

A Minimal Subset of Seven Genes Associated with Tumor Hepatocyte Differentiation Predicts a Poor Prognosis in Human Hepatocellular Carcinoma
por: Matthis Desoteux, et al.
Publicado: (2021)

Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis
por: Zongcai Yan, et al.
Publicado: (2021)

High Pregnane X Receptor (PXR) Expression Is Correlated with Poor Prognosis in Invasive Breast Carcinoma
por: Stamatios Theocharis, et al.
Publicado: (2021)

Development and Validation of an Autophagy-Related Gene Signature for Predicting the Prognosis of Hepatocellular Carcinoma
por: Jianlin Zhang, et al.
Publicado: (2021)

GTSE1 promotes cell migration and invasion by regulating EMT in hepatocellular carcinoma and is associated with poor prognosis
por: Xiaojuan Wu, et al.
Publicado: (2017)

A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the Patients
por: Dingde Ye, et al.
Publicado: (2021)

Cytoplasmic Skp2 expression is associated with p-Akt1 and predicts poor prognosis in human breast carcinomas.
por: Jing Liu, et al.
Publicado: (2012)

Lower mean platelet volume predicts poor prognosis in renal cell carcinoma
por: Zhi-yuan Yun, et al.
Publicado: (2017)

Activation of Akt/mTOR pathway is associated with poor prognosis of nasopharyngeal carcinoma.
por: Weiyuan Wang, et al.
Publicado: (2014)

An lncRNA Model for Predicting the Prognosis of Hepatocellular Carcinoma Patients and ceRNA Mechanism
por: Hao Zhang, et al.
Publicado: (2021)

Identification of the Immune Cell Infiltration Landscape in Hepatocellular Carcinoma to Predict Prognosis and Guide Immunotherapy
por: Shiyan Yang, et al.
Publicado: (2021)

The androgen receptor expression and its activity have different relationships with prognosis in hepatocellular carcinoma
por: S. Acosta-Lopez, et al.
Publicado: (2020)

High expression of WNT7A predicts poor prognosis and promote tumor metastasis in pancreatic ductal adenocarcinoma
por: Dong-jin Wu, et al.
Publicado: (2018)

Upregulate KIF4A Enhances Proliferation, Invasion of Hepatocellular Carcinoma and Indicates poor prognosis Across Human Cancer Types
por: Guojun Hou, et al.
Publicado: (2017)

Liver-enriched Genes are Associated with the Prognosis of Patients with Hepatocellular Carcinoma
por: Binghua Li, et al.
Publicado: (2018)

Activation of T helper cells in sentinel node predicts poor prognosis in oral squamous cell carcinoma
por: Åsa Kågedal, et al.
Publicado: (2020)

Elevated preoperative platelet distribution width predicts poor prognosis in Esophageal Squamous Cell Carcinoma
por: Qian Song, et al.
Publicado: (2019)

A Novel Nine-Gene Signature Associated With Immune Infiltration for Predicting Prognosis in Hepatocellular Carcinoma
por: Rongqiang Liu, et al.
Publicado: (2021)

Glycolysis-related gene expression profiling serves as a novel prognosis risk predictor for human hepatocellular carcinoma
por: Lingyu Zhang, et al.
Publicado: (2021)

A ceRNA-associated risk model predicts the poor prognosis for head and neck squamous cell carcinoma patients
por: Yuzi Xu, et al.
Publicado: (2021)

Highly expressed of SERPINA3 indicated poor prognosis and involved in immune suppression in glioma
por: Qing Yuan, et al.
Publicado: (2021)

Identification and Validation of Pyroptosis-Related Gene Signature to Predict Prognosis and Reveal Immune Infiltration in Hepatocellular Carcinoma
por: Xiao-Wei Fu, et al.
Publicado: (2021)

Increased platelet distribution width predicts poor prognosis in melanoma patients
por: Na Li, et al.
Publicado: (2017)

DNAJB11 predicts a poor prognosis and is associated with immune infiltration in thyroid carcinoma: a bioinformatics analysis
por: Rongxin Sun, et al.
Publicado: (2021)

Bioinformatics analysis identifies DYNC1I1 as prognosis marker in male patients with liver hepatocellular carcinoma.
por: Jian Zhou, et al.
Publicado: (2021)

Bioinformatics analysis identifies DYNC1I1 as prognosis marker in male patients with liver hepatocellular carcinoma
por: Jian Zhou, et al.
Publicado: (2021)

Computational Identification of Immune- and Ferroptosis-Related LncRNA Signature for Prognosis of Hepatocellular Carcinoma
por: Anmin Huang, et al.
Publicado: (2021)

Combination of intratumoral invariant natural killer T cells and interferon-gamma is associated with prognosis of hepatocellular carcinoma after curative resection.
por: Yong-Sheng Xiao, et al.
Publicado: (2013)

The immune checkpoint VISTA exhibits high expression levels in human gliomas and associates with a poor prognosis
por: Amina Ghouzlani, et al.
Publicado: (2021)

Combined prognostic nutritional index and albumin-bilirubin grade to predict the postoperative prognosis of HBV-associated hepatocellular carcinoma patients
por: Xie Liang, et al.
Publicado: (2021)

Geriatric nutritional risk index predicts prognosis in hepatocellular carcinoma after hepatectomy: a propensity score matching analysis
por: Hiroki Kanno, et al.
Publicado: (2021)

A Mutation-Related Long Noncoding RNA Signature of Genome Instability Predicts Immune Infiltration and Hepatocellular Carcinoma Prognosis
por: Jianhua Wu, et al.
Publicado: (2021)